JAZZ

Jazz Pharmaceuticals plc

HealthcareBiotechnologyUSUSDPeers →

$225.92

-1.24%LiveJun 22, 2026

Market cap

$14.19B

52w range

105.00 – 243.32

P / E

—

EPS

—

Volume

979.92K

Revenue · FY

—

Explain this page

Arphra AIPlain-English read on Jazz Pharmaceuticals plc’s valuation

Enterprise value

$17.69B

Market cap

$14.11B

Net debt

—

Total debt

—

Cash & ST inv.

—

Capital structure

· balance sheet · 2026-06-20

Market capitalisation$14.11B

+ Total debt+—

− Cash & short-term investments−—

= Enterprise value$17.69B

Valuation

· key metrics · TTM

EV / EBITDA32.5×

EV / Sales4.0×

EV / FCF14.2×

Net debt / EBITDA6.6×

Debt / Equity—

Arphra AIPlain-English read on the EV build & leverage